In one paragraphArticle in Research square, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 11 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
34 authors at 9 institutions in 3 countries.
Leeroy BaronInstitut Curie.
Sebastian MüllerInstitut Curie, CNRS, INSERM, PSL Research University, Equipe Labellisée Ligue Contre le Cancer.ORCID 0000-0002-3423-5364 Alanis CarmonaHarvard T. H. Chan School of Public Health.
Ludovic ColombeauInstitut Curie.
Julio SampaioInstitut Curie.
Eikan MishimaInstitute of Metabolism and Cell Death, Molecular Targets & Therapeutics Center, Helmholtz Munich, Neuherberg, Germany.ORCID 0000-0002-3706-2745 Armel Picard-BernesInstitut Curie.
Stéphanie SolierInstitut Curie.
Jiashuo ZhengHelmholtz Zentrum München.
Leishemba ThoidingjamInstitut Curie.
Laurence GrimaudENS.
Krystina SzyloHarvard T. H. Chan School of Public Health.
Caroline BonnetInserm.
Emmanuelle CharafeInserm.
Christophe GinestierInserm.
Patricia SantofimiaInserm.
Nelson DusettiCentre de Recherche en Cancérologie de Marseille, CRCM, Inserm, CNRS, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.ORCID 0000-0002-6161-8483 Gabriella PittauAPHP.
Pascal HammelAPHP.
Dimitri TzanisInstitut Curie.
Sylvie BonvalotInstitut Curie.
Marcus ConradInstitute of Metabolism and Cell Death, Molecular Targets & Therapeutics Center, Helmholtz Munich, Neuherberg, Germany.ORCID 0000-0003-1140-5612 Institut Curie · FRInserm · FRHarvard University · USHelmholtz Zentrum München · DETarget (Germany) · DECentre de Recherche en Cancérologie de Marseille · FRCentre National de la Recherche Scientifique · FRColumbia University Irving Medical Center · USHarvard University Press · US
Funding
Training Program in Molecular MetabolismT32DK128781 · NIDDK · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Sudha B Biddinger, GOKHAN S HOTAMISLIGIL · 2021 to 2026
$1.1MNIDDK NIH HHS T32 DK128781
6 · The paper itselfAbstract
Iron catalyses the oxidation of lipids in biological membranes and promotes a form of cell death referred to as ferroptosis
Identifiers
PMID38659936
PMCPMC11042398
OpenAlexW4394572004
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390